webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG8-propionic acid

  CAS No.: 756526-02-0   Cat No.: BADC-01153   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG8-propionic acid combines Fmoc protective groups with an 8-unit PEG spacer, optimizing ADC linker stability and solubility. This intermediate supports precise antibody conjugation and controlled drug release in targeted antibody-drug conjugates.

Fmoc-N-amido-PEG8-propionic acid

Structure of 756526-02-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C34H49NO12
Molecular Weight
663.75
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at -20°C, keep in dry and avoid sunlight

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-N-amido-PEG8-acid; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28-nonaoxa-4-azahentriacontan-31-oic acid; Fmoc-NH-PEG8-CH2CH2COOH; 1-(Fmoc-amino)-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oic Acid; Fmoc-PEG8-propionic acid; 5,8,11,14,17,20,23,26-Octaoxa-2-azanonacosanedioic acid, 1-(9-fluren-9-ylmethyl)ester; 2,7,10,13,16,19,22,25,28-Nonaoxa-4-azahentriacontan-31-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-
IUPAC Name
3-[2-[2-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O
InChI
InChI=1S/C34H49NO12/c36-33(37)9-11-39-13-15-41-17-19-43-21-23-45-25-26-46-24-22-44-20-18-42-16-14-40-12-10-35-34(38)47-27-32-30-7-3-1-5-28(30)29-6-2-4-8-31(29)32/h1-8,32H,9-27H2,(H,35,38)(H,36,37)
InChIKey
VYXGUCLTEWCVRY-UHFFFAOYSA-N
Density
1.190±0.06 g/cm3
Solubility
Soluble in DMSO (10 mm)
PSA
149.47000
Appearance
Colourless to pale yellow liquid
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20°C, keep in dry and avoid sunlight
Boiling Point
781.1±60.0 °C at 760 mmHg
Form
Liquid

Fmoc-N-amido-PEG8-propionic acid, a versatile reagent widely employed in peptide chemistry and drug development, boasts diverse applications. Here are four key applications of Fmoc-N-amido-PEG8-propionic acid:

Peptide Synthesis: Serving as a critical component in solid-phase peptide synthesis, Fmoc-N-amido-PEG8-propionic acid functions as a vital linker. It streamlines the attachment of polyethylene glycol (PEG) chains to peptides, enhancing solubility and mitigating aggregation concerns. This modification proves especially valuable for synthesizing lengthy or hydrophobic peptides.

Drug Conjugation: In the realm of drug development, Fmoc-N-amido-PEG8-propionic acid plays a pivotal role in conjugating drugs to targeted delivery systems. PEGylation facilitated by this reagent bolsters drug stability and extends its half-life in the bloodstream, while concurrently reducing immunogenicity.

Protein Modification: Unlocking a spectrum of biomedical applications, Fmoc-N-amido-PEG8-propionic acid enables the modification of proteins for diverse purposes. By affixing PEG chains to proteins, researchers elevate protein solubility and stability, augmenting their therapeutic efficacy.

Surface Functionalization: Delving into the realm of biosensing and bioengineering, Fmoc-N-amido-PEG8-propionic acid emerges as a linchpin for surface functionalization. Leveraging PEGylation, surfaces can be shielded against nonspecific protein adsorption, fostering enhanced biocompatibility. This process stands as a linchpin for crafting robust and sensitive biosensors, as well as engineering biomaterials essential for medical devices, illuminating the pivotal role this reagent plays in driving innovation in bioscience.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: (2,5-dioxopyrrolidin-1-yl) 5-[[3-(2,5-dioxopyrrolidin-1-yl)oxycarbonyl-4-nitrocyclohexyl]disulfanyl]-2-nitrobenzoate | 2,5-dioxopyrrolidin-1-yl 4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoate | Amino-SS-PEG12-acid | γ-Amanitin | MCC-DM1
Send Inquiry
Verification code
Inquiry Basket